News & Events

Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC).  The study, which compared the characteristics of primary and metastatic tumors, provides new insights into the biology of these aggressive cancers and potential ways to treat them.

In the...

Branden Sosa was halfway through his undergraduate degree at Hunter College when he had to take time off from school—his mother had been diagnosed with breast cancer. For a year and a half, he worked at Hospital for Special Surgery as an office manager to support his family.

“It was through that experience I grew to love orthopedics and research...

Weill Cornell Medicine investigators discovered that unique bacteria colonize the gut shortly after birth and make the neurotransmitter serotonin to educate gut immune cells. This prevents allergic reactions to food and the bacteria themselves during early development.

The preclinical study, published in Science Immunology on Mar. 15, showed that bacteria abundant in the guts of newborns produce serotonin, which...

Specialized nursing facility clinicians, or SNFists, may decrease the likelihood of nursing home residents experiencing stressful hospitalizations and improve the quality of life in their last days, according to researchers from Weill Cornell Medicine.

The study, published in JAMA Network Open on Mar. 15, examined how SNFists uniquely impacted the care of nursing home residents in their last 90 days,...

Rampant mistrust of medical science during the COVID-19 pandemic represents the rule, not the exception, of public perception of mainstream medicine over the last two centuries, said Lewis A. Grossman, a distinguished professor of law at American University’s Washington College of Law, in a lecture at Weill Cornell Medicine on March 13. 

“In October 2023, the Pew Research Center found that only 25 percent of U.S. adults say they have great...

Researchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost. The protocol shortened the time it took participants to attend an HIV clinic and to start on antiretroviral therapy after discharge.

However, the study published in JAMA on Mar. 6 found that the care benefits didn’t translate...

Christine Ye traces her passion for medicine back to seventh grade, when she joined a medical mission to Haiti and saw first-hand how access to health care can create stark disparities.

“I remember thinking, ‘This issue could have been solved with a vitamin supplement, or a bandaid, or neosporin—something simple,’” said Ye, 26, from Valley Stream, N.Y. “New York is such a different world, but even within New York there are disparities. That just stuck with me; seeing the injustice in...

A new study found that retinoic acid receptors (RARa) in the proximal tubules of the kidney play a crucial role in limiting the damaging effects of kidney injury that often lead to kidney failure. Researchers from Weill Cornell Medicine have developed a preclinical model that showed a condition like chronic kidney disease develops when RARa in proximal tubules stop working.

Currently, there are few drugs on the market, so patients with prolonged, untreated kidney disease must undergo...

Bruce Ratner, a familiar figure in the New York scene, is known for his work as a major property developer, including helping revive downtown Brooklyn’s economy, and as a former commissioner of consumer affairs. What most people don’t know is he is a strident advocate for the advancement of innovative cancer diagnostics. 

At the 2024 Startup Symposium & InvestConnect Conference, held Feb. 28 at Weill Cornell Medicine’s Belfer Research Building, Ratner, now a co-author of a new book...

Weill Cornell Medicine is part of an international team that has been awarded funding of up to $25 million over five years by Cancer Grand Challenges to study the causes of cancer inequities.

Cancer Grand Challenges is a global funding initiative co-founded by the National Cancer Institute and Cancer Research UK that aims to address key challenges in cancer biology and patient care.

Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators. They have conducted the first whole genome sequencing analysis of male breast cancer, which looked at the complete DNA landscape of tumor samples from 10 patients.

This is an important step in viewing breast cancer in men, which represents less than 1 percent of all breast cancer cases each year, as a unique disease...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO in Haiti. Second-line medications are those that are given when one or more of the drugs given first for the disease are not effective. The research could have implications for...

A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation. The results, published in Cell Medicine Reports on Feb. 23, suggested that this “gene signature” could be used to identify a subclass of lung tumors that is more likely to be eradicated...

Individuals with eating disorders who have low income are frequently misdiagnosed and lack adequate access to appropriate therapy, according to researchers from Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons.

Their...

Although it is one of the oldest medications used to treat patients with inflammatory bowel disease (IBD) and an effective treatment for an associated arthritis condition called spondyloarthritis (SpA), sulfasalazine’s mechanism of action has been unclear. Now researchers at the Jill Roberts Center for IBD and the Jill Roberts Institute for Research in IBD at Weill Cornell Medicine and...

NEW YORK (Feb. 16, 2023)—Dr. Juan Pascual, a leading pediatric neurologist, has been appointed chief of the Division of Child Neurology in the Department of Pediatrics at NewYork-Presbyterian Komansky Children’s Hospital and Weill Cornell Medicine, effective March 1.

 In his new role, Dr. Pascual will oversee the child and neonatal neurology divisions with a focus on increasing access to high-quality care, expanding scientific research, and recruiting and developing...

Structural rearrangements allow pH-dependent activation of CLC-e1. The video depicts the molecular movements of the CLC transporter from the inactive state to its two active conformations.

The molecular workings of a family of important but hard-to-study proteins called CLCs have been illuminated as never before in a study led by researchers at Weill Cornell Medicine.

CLCs play fundamental roles in biology by regulating the levels of chloride and other ions in...

NEW YORK (February 13, 2023) — Dr. Jennie G. Ono, a leading pediatrician who focuses on inpatient care, newborn medicine and pediatric asthma, has been appointed chief of pediatrics at NewYork-Presbyterian Queens. Dr. Ono also serves as an associate professor of clinical pediatrics at Weill Cornell Medicine.

In her new role, Dr. Ono will continue to grow the pediatric primary care, subspecialty and inpatient programs at...

NEW YORK (Feb. 13, 2024) — Dr. Sumit Gupta, a physician-scientist whose research focuses on vulnerable subpopulations of children with cancer, has been awarded the eighth annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today. 

The Drukier Prize honors an early-career pediatrician whose research promises to make significant contributions toward improving the health of children and adolescents. Dr. Gupta is an associate...

NewYork-Presbyterian/Weill Cornell Medical Center has received the Mitral Valve Repair Reference Center Award from the American Heart Association and the Mitral Foundation for a demonstrated record of superior clinical outcomes resulting from evidence-based, guideline-directed degenerative mitral valve repair.

This award recognizes NewYork-Presbyterian/Weill Cornell Medical Center’s contribution to advancing best practices in the surgical treatment of mitral valve disease...